26 Mar 2019 --- Technology-focused specialty pharmaceutical company Tenshi Kaizen Private, Ltd., and US-based DolCas Biotech, LLC are creating a joint-venture company – DolCas-Tenshi Bioceuticals, Inc (DTB). The new enterprise will focus exclusively on the research, development, and commercialization of novel nutraceutical lines for key global markets, including the US, Canada, Europe and Japan.
